(Reuters) -Drugmaker Regeneron Pharmaceuticals is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million. The once-sizzling DNA-testing startup filed for ...
The story of bringing dire wolves back from extinction begins not in a laboratory, but in ancient deposits where their remains lay buried for millennia. The genetic material that would eventually give ...
In the last decade, the drive to understand who we are and where we've come from has been accelerated by DNA testing. So far, around 40 million people worldwide have used direct-to-consumer genetic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results